22 May, 2019 03:10 PM
Melbourne, Australia, 22 May 2019: Sienna Cancer Diagnostics Ltd (ASX: SDX) (“Sienna” or “The Company”), a medical technology company developing and commercialising innovative ...read more
21 May, 2019 03:36 PM
Melbourne, Australia, 21 May 2019: Sienna Cancer Diagnostics Ltd (ASX: SDX) (“Sienna” or “the Company”), a commercial stage, medical technology company, recently conducted a vi...read more
18 Mar, 2019 03:21 PM
Inside Diagnosticos appointed as exclusive distributor
Brazil is a major market with significant opportunity for growth
Melbourne, Australia, 18 March 2019: Sienna Cancer Diagnostics...read more
13 Mar, 2019 05:17 PM
Sienna Cancer Diagnostics Ltd, (ASX:SDX), a medical technology company developing and commercialising innovative cancer-related tests, is pleased to notify shareholders of a FNN interview with Sie...read more
04 Feb, 2019 09:49 AM
Mediwell Enterprise Pte. Ltd (Mediwell) appointed as distribution partner for Singapore.
Singapore has a fast-growing market for in-vitro diagnostic (IVD) tests.
Melbourne, Australia, 04 Feb 2...read more
22 Jan, 2019 11:14 AM
Mirax Corporation appointed as exclusive distributor for Korea
Important expansion of commercial opportunity in high-growth Asian IVD market
Melbourne, Australia, 22 January 2019: Sienna Cance...read more
31 Jul, 2018 11:25 AM
Melbourne, Australia, 31 July 2018: Sienna Cancer Diagnostics Ltd, (ASX:SDX) (“Sienna” or “the Company”), a medical technology company developing and commercialising innovative...read more
07 Jun, 2018 02:06 PM
Study was performed on 500 urine specimens, making it the largest to date
Published in Acta Cytologica, a leading cytopathology journal
Expected to result in increased uptake of Sienna’...read more
22 May, 2018 06:00 PM
Melbourne, Australia, 22 May 2018: Sienna Cancer Diagnostics Ltd, (ASX:SDX) (“Sienna” or “The Company”), a medical technology company developing and commercialising innovative ...read more
30 Apr, 2018 03:18 PM
Cash position $2.9m
R&D tax refund for 2017 expected in quarter ending June 2018
Melbourne, Australia, 30 April 2018: Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or &ldqu...read more
22 Mar, 2018 03:40 PM
500-patient study confirms clinical utility of hTERT testing as an adjunct to urine cytology
Study results were presented by Johns Hopkins at USCAP meeting in Vancouver
Melbourne, Australia, 2...read more